# Anavex Life Sciences Corp.: Form DEF 14A, filed May 6, 2024

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: DEF 14A
- Filed: 2024-05-06
- Accepted by EDGAR: May 6, 2024, 06:01 ET
- Period: 2024-05-06
- Accession: 0001731122-24-000730
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112224000730/e5638_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112224000730/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112224000730/e5638_def14a.htm

Filed May 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001731122-24-000730. Last ingested by Listed: Nov 6, 2026, 20:17 ET. No prices; not investment advice.